Navigation Links
Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States


NEW YORK, Sept. 14 /PRNewswire/ -- The following is being issued by Pfizer Inc:

WHAT: The upcoming episode of the Charlie Rose Science Series will

discuss the global burden of cardiovascular disease, the leading

cause of mortality worldwide. A panel of experts will explore the

biology and genetics of the disease, prevention and treatment, the

development of medical, surgical and interventional therapies, and

steps individuals can take toward a heart-healthy lifestyle.

WHO: Guests will include:

-- Steven E. Nissen, MD, MACC, Chairman of Cleveland Clinic

Department of Cardiovascular Medicine

-- Lori Mosca, MD, MPH, PhD, Director of Preventive Cardiology, New

York Presbyterian Hospital

-- Harlan Krumholz, MD, Harold H. Hines Junior Professor of Medicine

and Epidemiology and Public Health, Yale University School of


-- Lance Becker, MD, Director of the Center for Resuscitation

Science at the University of Pennsylvania

WHEN: Begins Airing on September 19, 2007 on PBS stations. Check your

local PBS listings for show times.


The Charlie Rose Science Series sponsored by Pfizer Inc is an exploration of modern advances in scientific research, their contribution to our understanding of the world around us, and how science breakthroughs can be applied to improving human health.

Charlie Rose is joined in this effort by his co-host, Sir Paul Nurse, PhD, Nobel Laureate and President of Rockefeller University.

As a world leader in research and development, Pfizer is committed to increasing public understanding of science and science education. For more information about The Charlie Rose Science Series or to watch clips from past episodes, please visit

SOURCE Pfizer Inc
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Flat panel displays
2. Panel stresses drawing outside biotech firms to state
3. National stem-cell panel, including UW profs, urges close watch on research
4. Star panel re-evaluates Sarbanes-Oxley one year in at SEC headquarters
5. Distance Education Conference Selects Sonic Foundry to Make Keynotes, Panel Presentations Available On-Demand
6. VC trends, company progress discussed at Mason Wells portfolio meeting
7. Rayovacs IT team discusses network security, Sarbanes-Oxley and ROI myths
8. State CIO discusses IT and government
9. Industry Veterans discuss the "next big thing"
10. Biotech Pioneer Discusses Breakthrough in Osteoporosis Treatment
11. Wisconsin Leaders Discuss Economic Development
Post Your Comments:
(Date:11/30/2015)... Md. , Nov. 30, 2015 ... development company committed to the fostering and monetization ... the current and prospective initiatives designed to create ... Chief Executive Officer of Spherix. "Based on published ... future licensees exceeds $50 billion and Spherix will ...
(Date:11/30/2015)... , Nov. 30, 2015  Champions Oncology, Inc. (CSBR), ... services to personalize the development and use of oncology ... Executive Officer, will be presenting at the LD MICRO ... Pacific Standard Time (PST).  The conference, held at the ... Angeles, CA , will feature 200 small/micro-cap companies ...
(Date:11/30/2015)... 30, 2015 TapImmune, Inc. ... of innovative peptide and gene-based immunotherapeutics and vaccines for ... it will be presenting at the 8 th ... at 2.30 PM PT. Dr. John N. Bonfiglio ... be giving the presentation and will join TapImmune management ...
(Date:11/30/2015)... , Nov. 30, 2015  Aytu BioScience, Inc. (OTCQB: ... and related conditions, will present at two upcoming investor ... an interactive real-time virtual conference, to be held December ... Conference, to be held December 2 nd & ... and streamed live via webcast. ...
Breaking Biology Technology:
(Date:11/9/2015)...  Synaptics Inc. (NASDAQ: SYNA ), the leading ... into the automotive market with a comprehensive and dedicated ... consumer electronics human interface innovation. Synaptics, industry-leading touch controllers, ... automotive industry and will be implemented in numerous locations ... , Japan , and ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
(Date:10/29/2015)... , Oct. 29, 2015  The J. Craig ... report titled, "DNA Synthesis and Biosecurity: Lessons Learned and ... Department of Health and Human Services guidance for synthetic ... 2010. --> --> ... also has the potential to pose unique biosecurity threats. ...
Breaking Biology News(10 mins):